Drug Information Association Logo

Continuing Education Credits

At the conclusion of this conference, participants should be able to:

  • Define how the evolving health care environment will affect orphan product development and investment
  • Discuss how the government and private sector are addressing special challenges faced by patients and companies
  • Explain the unique challenges faced by patients with rare diseases and the organizations that represent the patients
  • Discuss how to develop better communication among the investigator, patient, industry, investor and government influencers in the rare disease/orphan product community
  • Discuss updates on recent initiatives for rare disease research and drug development by incorporating the perspectives of multiple stakeholder groups
  • Synthesize didactic information with examples from case studies used to illustrate early research and development, natural history studies, clinical trial design and statistical analysis, endpoint development, and post-marketing opportunities
  • Recognize the importance of collaboration in rare disease drug development through examples of success stories

PIM This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and the Drug Information Association. PIM is accredited by the ACCME to provide continuing medical education for physicians.

PIM designates this live activity for a maximum of 21 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

IACETDrug Information Association has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102.

As an IACET Authorized Provider, Drug Information Association offers CEUs for its programs that qualify under the ANSI/IACET Standard.  Drug Information Association is authorized by IACET to offer 2.1 CEUs for this program. Participants must attend the entire program in order to be able to receive an IACET statement of credit. No partial credit will be awarded.

If you would like to receive a statement of credit, you must attend the program, scan your name badge at the DIA registration desk each day of the program, and complete the on-line credit request process through My Transcript. To access My Transcript, please go to www.diahome.org, select “Login to My DIA” and you will be prompted for your user ID and password. Select “My Transcript” (left side bar) and “Credit Request” to process your credit request. Participants will be able to download a statement of credit upon successful submission of the credit request. My Transcript will be available for credit requests on November 7, 2012.

DIA’s Certificate Program Statement
This program is part of DIA’s Certificate Program and is awarded the following:

  • Clinical Research Certificate Program: 12 Elective Units

Read more information

Disclosure of Conflicts of Interest
The Postgraduate Institute for Medicine (PIM) and DIA require instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity.  All identified conflicts of interest are thoroughly vetted by PIM and DIA for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.

View DIA’s Grievance Policy.

Americans with Disabilities (ADA)
Reasonable accommodations will be made available to persons with disabilities who attend an educational activity. Contact the DIA office in writing at least 15 days prior to event to indicate your needs.
© 2014